statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NuCana plc (NASDAQ:NCNA  Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,480,000...

NuCana plc (NASDAQ:NCNA) Sees Significant Growth in Short Interest

In a report released today, Robyn Karnauskas from Truist Financial maintained a Buy rating on Nucana (NCNA Research Report). The company's shares...

Truist Financial Sticks to Its Buy Rating for Nucana (NCNA)

NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs).
read more...

Why NuCana (NCNA) Shares Are Trading Lower

EDINBURGH, United Kingdom, March 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced plans to change the ratio of its American Depository Shares ( ADSs ) to its ordinary shares from...

NuCana Announces Plan to Implement ADS Ratio Change

Short Interest in NuCana plc (NASDAQ:NCNA) Expands By 2,616.3%

NuCana plc (NASDAQ:NCNA  Free Report)  Stock analysts at William Blair issued their FY2024 EPS estimates for NuCana in a research note issued to investors on Thursday, March 21st...

William Blair Comments on NuCana plc's FY2024 Earnings (NASDAQ:NCNA)

NuCana GAAP EPS of -?0.14

Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024...

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Gagnants
Le titre NuCana (NASDAQ:NCNA) a mont mercredi de 39,62% 0,54 dollars lors de la session ordinaire.
Le titre Kintara Therapeutics (NASDAQ:KTRA) a grimp de 36,96% 0,11 dollars.
L'action...

12 titres de soins de sant  en mouvement lors de la session du 13/03/2024

Titoli in rialzo
Le azioni di Kintara Therapeutics (NASDAQ:KTRA) hanno guadagnato il 39,27% a 0,12 dollari durante la sessione regolare di mercoled .
Il titolo NuCana (NASDAQ:NCNA) ha avuto un...

12 titoli sanitari in movimento, sessione regolare del 13/03/2024

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

Volume	28,655.00
52-Wk High	$23.75
52-Wk Low	$3.40

NCNA NuCana plc

About

Feed

News

Sentiment

Fundamentals